News

Filter

Milestone from Gedeon Richter as Palatin initiates Ph III bremelanotide study

Milestone from Gedeon Richter as Palatin initiates Ph III bremelanotide study

31-12-2014

US biopharma company Palatin Technologies says it has started its bremelanotide pivotal registration…

bremelanotideGedeon RichterLicensingPalatin TechnologiesPharmaceuticalResearchWomen's Health

Palatin licenses certain rights to Richter for bremelanotide

11-09-2014

USA-based Palatin Technologies and Hungary’s largest drugmaker Gedeon Richter have entered into a collaboration…

EuropeGedeon RichterLicensingPalatin TechnologiesPharmaceuticalWomen's Health

Richter and HRA Pharma in deal on Esmya for Latin America

30-05-2014

Hungary’s largest drugmaker Gedeon Richter and France-based Laboratoire HRA Pharma have concluded a…

EsmyaGedeon RichterHRA PharmaLicensingPharmaceuticalSouth AmericaWomen's Health

European Commission approves Gedeon Richter’s Esmya type II Variation

European Commission approves Gedeon Richter’s Esmya type II Variation

27-01-2014

The European Commission has granted marketing authorization to extend the use of Esmya (ulipristal acetate)…

EsmyaEuropeGedeon RichterPharmaceuticalRegulationWomen's Health

Two Latin America acquisitions for Gedeon Richter

23-12-2013

In what was a busy couple of days for Hungary’s largest drugmaker Gedeon Richter, the company announced…

BrazilGedeon RichterMergers & AcquisitionsNext PharmaPharmaceuticalSouth AmericaWomen's Health

Back to top